MID-VOLUME · HOSP-HEAVY
voriconazole Side Effects
voriconazole (also sold as Vfend) sits MID-VOLUME #195 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 40.1% mention hospitalization (11,781 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 29,380
- FAERS reports
FDA Adverse Event Reporting System extract for voriconazole. Stamp set CASELOAD · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
voriconazole: 40.1% mention hospitalization (11,781 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #195 of 524 by FAERS report count.
Mid-book FAERS page for voriconazole (Vfend) (29,380 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DRUG INTERACTION leads 2,315 of 29,380 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (7,577 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (8,672 reports, 29.5%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,456 |
| PNEUMONIA | 615 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 587 |
| RESPIRATORY FAILURE | 586 |
| SEPTIC SHOCK | 506 |
| BRONCHOPULMONARY ASPERGILLOSIS | 447 |
| PYREXIA | 444 |
| CONDITION AGGRAVATED | 436 |
| SEPSIS | 410 |
| ASPERGILLUS INFECTION | 359 |
| DISEASE PROGRESSION | 308 |
| RENAL FAILURE | 286 |
| FEBRILE NEUTROPENIA | 270 |
| DRUG RESISTANCE | 268 |
| ACUTE MYELOID LEUKAEMIA | 249 |
| FUNGAL INFECTION | 241 |
| NEUTROPENIA | 232 |
| DIARRHOEA | 229 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (11,781, 40.1% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DRUG INTERACTION | 980 |
| PYREXIA | 979 |
| PNEUMONIA | 913 |
| BRONCHOPULMONARY ASPERGILLOSIS | 655 |
| FEBRILE NEUTROPENIA | 607 |
| ASPERGILLUS INFECTION | 524 |
| RESPIRATORY FAILURE | 516 |
| CONDITION AGGRAVATED | 503 |
| DYSPNOEA | 471 |
| DIARRHOEA | 449 |
| SEPSIS | 420 |
| SEPTIC SHOCK | 403 |
| NAUSEA | 400 |
| NEUTROPENIA | 394 |
| ACUTE KIDNEY INJURY | 388 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 349 |
| ANAEMIA | 341 |
| PANCYTOPENIA | 324 |
How to read voriconazole FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 29,380 voluntary reports linked to voriconazole (Vfend), 2004-2025. Death is listed on 8,672 (29.5%). Hospitalization appears on 11,781 (40.1%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 40.1% mention hospitalization (11,781 reports).
Read with voriconazole
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 29,404 FAERS cases (Δ 24 heavier vs voriconazole); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 29,554 FAERS cases (Δ 174 heavier vs voriconazole); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 29,813 FAERS cases (Δ 433 heavier vs voriconazole); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 29,874 FAERS cases (Δ 494 heavier vs voriconazole); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 32.6 pp vs voriconazole's DEATH-HEAVY): CASELOAD · HOSP-MID.
voriconazole stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.